You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Epilepsy

Cannabidiol with clobazam for treating seizures associated with Dravet syndrome

  • Technology appraisal guidance
  • Reference number: TA614
  • Published:  18 December 2019
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final draft guidance
  3. Draft guidance: 1
  4. Invitation to participate
  5. Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

History

Documents created during the development process.

Expected publication

  • Equality impact assessment (Scoping) (PDF 158 KB)

    Published:
    18 December 2019

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 331 KB)

    Published:
    11 November 2019
  • Committee papers (PDF 2.4 MB)

    Published:
    11 November 2019

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (online commenting)

  • Appraisal consultation document (PDF version) (PDF 337 KB)

    Published:
    23 August 2019
  • Committee papers (PDF 7.86 MB)

    Published:
    23 August 2019
  • Public committee slides (PDF 1.22 MB)

    Published:
    23 August 2019

Invitation to participate

  • Final scope (PDF 255 KB)

    Published:
    31 October 2018
  • Final matrix (PDF 217 KB)

    Published:
    31 October 2018
  • NICE's response to comments on the draft scope and provisional matrix (PDF 260 KB)

    Published:
    31 October 2018
  • Equality impact assessment (Scoping) (PDF 176 KB)

    Published:
    31 October 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

  • Draft scope pre referral (PDF 351 KB)

    Published:
    28 November 2017
  • Draft matrix pre referral (PDF 217 KB)

    Published:
    28 November 2017
Back to top